MLTX
Price
$20.41
Change
+$0.05 (+0.25%)
Updated
Jul 13 closing price
Capitalization
1.71B
29 days until earnings call
Intraday BUY SELL Signals
RARE
Price
$33.22
Change
-$0.60 (-1.77%)
Updated
Jul 13 closing price
Capitalization
3.27B
16 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MLTX vs RARE

MLTX vs RARE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MLTX vs. RARE commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Buy and RARE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (MLTX: $20.41 vs. RARE: $33.22)
Brand notoriety: MLTX and RARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 70% vs. RARE: 35%
Market capitalization -- MLTX: $1.71B vs. RARE: $3.27B
MLTX [@Biotechnology] is valued at $1.71B. RARE’s [@Biotechnology] market capitalization is $3.27B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 0 FA rating(s) are green whileRARE’s FA Score has 0 green FA rating(s).

  • MLTX’s FA Score: 0 green, 5 red.
  • RARE’s FA Score: 0 green, 5 red.
According to our system of comparison, MLTX is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 6 TA indicator(s) are bullish while RARE’s TA Score has 6 bullish TA indicator(s).

  • MLTX’s TA Score: 6 bullish, 4 bearish.
  • RARE’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both MLTX and RARE are a good buy in the short-term.

Price Growth

MLTX (@Biotechnology) experienced а +8.10% price change this week, while RARE (@Biotechnology) price change was -1.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

MLTX is expected to report earnings on Aug 12, 2026.

RARE is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RARE($3.27B) has a higher market cap than MLTX($1.71B). MLTX YTD gains are higher at: 54.856 vs. RARE (44.435). MLTX has higher annual earnings (EBITDA): -245.81M vs. RARE (-502M). RARE has more cash in the bank: 413M vs. MLTX (358M). RARE has less debt than MLTX: RARE (36M) vs MLTX (101M). RARE has higher revenues than MLTX: RARE (670M) vs MLTX (0).
MLTXRAREMLTX / RARE
Capitalization1.71B3.27B52%
EBITDA-245.81M-502M49%
Gain YTD54.85644.435123%
P/E RatioN/AN/A-
Revenue0670M-
Total Cash358M413M87%
Total Debt101M36M281%
FUNDAMENTALS RATINGS
RARE: Fundamental Ratings
RARE
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MLTXRARE
RSI
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 18 days ago
78%
Declines
ODDS (%)
Bearish Trend 12 days ago
77%
Bearish Trend 1 day ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signal:
Gain/Loss:
RARE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DFGR29.330.10
+0.36%
Dimensional Global Real Estate ETF
IMF51.420.02
+0.03%
Invesco Managed Futures Strategy ETF
VGUS75.53N/A
N/A
Vanguard Ultra-Short Treasury ETF
GNMA43.88N/A
N/A
iShares GNMA Bond ETF
NMS12.15-0.08
-0.61%
Nuveen Minnesota Quality Municipal Income Fund

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.25%
KALA - MLTX
82%
Closely correlated
-7.23%
XNCR - MLTX
50%
Loosely correlated
-5.62%
NUVL - MLTX
48%
Loosely correlated
+0.03%
NRIX - MLTX
45%
Loosely correlated
-1.52%
XENE - MLTX
44%
Loosely correlated
-1.74%
More

RARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, RARE has been closely correlated with MREO. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if RARE jumps, then MREO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RARE
1D Price
Change %
RARE100%
-1.77%
MREO - RARE
78%
Closely correlated
-4.18%
VCYT - RARE
46%
Loosely correlated
+0.90%
INO - RARE
38%
Loosely correlated
-1.69%
MLTX - RARE
37%
Loosely correlated
+0.25%
AMRN - RARE
36%
Loosely correlated
-1.21%
More